The change in the expression of α6 integrin and uPA/uPAR was investigated in OVHS 1, PEO.36, OVCA 433 and HEY cell lines with five different samples of ascites obtained from patients diagnosed with Stage 2 and Stage 3 ovarian cancer. The gene discussed is PLAUR; the disease is ovarian cancer.